149 related articles for article (PubMed ID: 25937014)
1. 2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro.
Řezníčková E; Popa A; Gucký T; Zatloukal M; Havlíček L; Bazgier V; Berka K; Jorda R; Popa I; Nasereddin A; Jaffe CL; Kryštof V; Strnad M
Bioorg Med Chem Lett; 2015 Jun; 25(11):2298-301. PubMed ID: 25937014
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity.
Grant KM; Dunion MH; Yardley V; Skaltsounis AL; Marko D; Eisenbrand G; Croft SL; Meijer L; Mottram JC
Antimicrob Agents Chemother; 2004 Aug; 48(8):3033-42. PubMed ID: 15273118
[TBL] [Abstract][Full Text] [Related]
3. High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.
Walker RG; Thomson G; Malone K; Nowicki MW; Brown E; Blake DG; Turner NJ; Walkinshaw MD; Grant KM; Mottram JC
PLoS Negl Trop Dis; 2011 Apr; 5(4):e1033. PubMed ID: 21483720
[TBL] [Abstract][Full Text] [Related]
4. Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents.
Rashid U; Sultana R; Shaheen N; Hassan SF; Yaqoob F; Ahmad MJ; Iftikhar F; Sultana N; Asghar S; Yasinzai M; Ansari FL; Qureshi NA
Eur J Med Chem; 2016 Jun; 115():230-44. PubMed ID: 27017551
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
7. Anti-leishmanial activity of disubstituted purines and related pyrazolo[4,3-d]pyrimidines.
Jorda R; Sacerdoti-Sierra N; Voller J; Havlíček L; Kráčalíková K; Nowicki MW; Nasereddin A; Kryštof V; Strnad M; Walkinshaw MD; Jaffe CL
Bioorg Med Chem Lett; 2011 Jul; 21(14):4233-7. PubMed ID: 21683592
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.
Yousuf M; Mukherjee D; Pal A; Dey S; Mandal S; Pal C; Adhikari S
ChemMedChem; 2015 Mar; 10(3):546-54. PubMed ID: 25619822
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
[TBL] [Abstract][Full Text] [Related]
11. The crk3 gene of Leishmania mexicana encodes a stage-regulated cdc2-related histone H1 kinase that associates with p12.
Grant KM; Hassan P; Anderson JS; Mottram JC
J Biol Chem; 1998 Apr; 273(17):10153-9. PubMed ID: 9553063
[TBL] [Abstract][Full Text] [Related]
12. Leishmania mexicana: expression; characterization and activity assessment of E. coli-expressed recombinant CRK3.
Ali NO; Ibrahim ME; Grant KM; Mottram JC
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1338-45. PubMed ID: 23104649
[TBL] [Abstract][Full Text] [Related]
13. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
14. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis.
Saad SM; Ghouri N; Perveen S; Khan KM; Choudhary MI
Eur J Med Chem; 2016 Jan; 108():13-20. PubMed ID: 26619389
[TBL] [Abstract][Full Text] [Related]
15. Leishmania donovani pteridine reductase 1: biochemical properties and structure-modeling studies.
Kumar P; Kumar A; Verma SS; Dwivedi N; Singh N; Siddiqi MI; Tripathi RP; Dube A; Singh N
Exp Parasitol; 2008 Sep; 120(1):73-9. PubMed ID: 18617167
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-5-substituted-1,3,4-thiadiazole derivatives.
Foroumadi A; Emami S; Pournourmohammadi S; Kharazmi A; Shafiee A
Eur J Med Chem; 2005 Dec; 40(12):1346-50. PubMed ID: 16095763
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines.
Gamage SA; Figgitt DP; Wojcik SJ; Ralph RK; Ransijn A; Mauel J; Yardley V; Snowdon D; Croft SL; Denny WA
J Med Chem; 1997 Aug; 40(16):2634-42. PubMed ID: 9258370
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of purine and pyrimidine analogues on Leishmania donovani and Leishmania infantum promastigotes and intracellular amastigotes.
Azzouz S; Lawton P
Acta Parasitol; 2017 Sep; 62(3):582-588. PubMed ID: 28682767
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents.
Marhadour S; Marchand P; Pagniez F; Bazin MA; Picot C; Lozach O; Ruchaud S; Antoine M; Meijer L; Rachidi N; Le Pape P
Eur J Med Chem; 2012 Dec; 58():543-56. PubMed ID: 23164660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
